Our Research

Research

At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients. 


Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.


Injectable Nanoparticle Generator For Metastatic Breast Cancer Treatment

Mauro Ferrari, PhD, president and CEO of the Houston Methodist Research Institute, and his team have developed the first drug delivery system to successfully eliminate lung metastases in mice models with triple negative breast cancer. Learn more.

COMMON ANTACID LINKED TO VASCULAR AGING AND HEART ATTACK

Houston Methodist researchers led by John P. Cooke, MD, PhD show that Proton Pumps Inhibitors cause accelerated vascular aging leading to increased risk for heart disease, dementia and renal failure. Watch Dr. Cooke discuss his new paper.

FIRST RAPID ZIKA VIRUS DIRECT TEST NOW AVAILABLE

Investigators from Houston Methodist and Texas Children's hospital develop country’s first hospital-based rapid test for the Zika virus. James M. Musser, MD, PhD, led the Houston Methodist team along with Randall J. Olsen, MD, PhD. Learn more.

Meet Tetsuo Ashizawa, MD, Director of Neurosciences

Tetsuo Ashizawa, MD, leading translational neuroscientist, joins Houston Methodist Research Institute as the new Director of Neurosciences. Learn More.